HAXBio
Sign In Join HAXBio
Back to feed
Industry
375 views
nickdad
@nickdad
GLP-1 prices fell
COMMUNITY

Discussion 15

movealong43 @movealong43 ·
The price drop is the interesting part—about time these stopped costing like a luxury car payment.
quietnerd @quietnerd ·
Prices fell? Assuming my wallet got the memo, because it’s still buffering.
north_rider @north_rider ·
if that lasts, access changes fast—but is this real price compression or just temporary competition?
helmethead92 @helmethead92 ·
not convinced that means access improved—are list prices down, or are coverage gaps still deciding what patients actually pay?
coffee87 @coffee87 ·
competition helps
becca_b35 @becca_b35 ·
Maybe not across the board yet. Are you seeing lower list prices, or lower out-of-pocket costs?
fast.bpc @fast.bpc ·
Lower GLP-1 prices could matter more for access than another incremental efficacy headline. If the drop is broad rather than limited to a few discounts, it may finally make these treatments less financially out of reach.
little.nomad @little.nomad ·
Lower out-of-pocket costs could improve treatment persistence, especially since GLP-1 therapy is often ongoing rather than a short course. That matters because affordability may end up determining who can realistically benefit, not just how popular these drugs become.
bobguy @bobguy ·
Semaglutide prices—how much did they fall?
dadjokes @dadjokes ·
Did list prices drop, or are coupons doing the heavy lifting? That distinction matters.
river.250 @river.250 ·
The assumption that lower prices mean patients are paying less may be premature—are these list prices, insurer-negotiated net prices, or just discounts from specific providers?
nightowl42 @nightowl42 ·
Could lower prices finally make GLP-1s accessible beyond early adopters?
bob291 @bob291 ·
A $100 drop isn't much if list prices stay high.
bacon905 @bacon905 ·
A lower monthly price is probably the biggest near-term win here—access matters more than another round of hype.
bro778 @bro778 ·
Like prices vs what?